SrasV1, PascalFrancis, Curation, bibRecord, 000416

Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets

Identifieur interne : 000416 ( PascalFrancis/Curation ); précédent : 000415; suivant : 000417

Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets

Auteurs : ZHONGPING HE [République populaire de Chine] ; CHUNHUI ZHAO [République populaire de Chine] ; QINGMING DONG [République populaire de Chine] ; HUI ZHUANG [République populaire de Chine] ; SHUJING SONG [République populaire de Chine] ; GUOAI PENG [République populaire de Chine] ; Dominic E. Dwyer [Australie]

Source :

International journal of infectious diseases [ 1201-9712 ] ; 2005.

RBID : Pascal:05-0496221

Descripteurs français

Pascal (Inist)
- Syndrome respiratoire aigu sévère, Bactériémie, Lymphopénie, Sous population cellulaire, Lymphocyte, Coronavirus, Antigène CD4, Antigène CD8.

English descriptors

KwdEn :
- Bacteremia, Cell subpopulation, Coronavirus, Lymphocyte, Lymphocytopenia, Severe acute respiratory syndrome.

Abstract

Introduction: Severe acute respiratory syndrome (SARS) caused large outbreaks of atypical pneumonia in 2003, with the largest localized outbreak occurring in Beijing, China. Lymphopenia was prominent amongst the laboratory abnormalities reported in acute SARS. Methods: The effect of SARS on peripheral blood lymphocytes and their subsets was examined in 271 SARS coronavirus-infected individuals. Results: There was a significant decrease in the CD45+, CD3+, CD4+, CD8+, CD19+ and CD16+/56+ cell counts over the five weeks of the SARS illness although CD4+/CD8+ ratios did not change significantly. The lymphopenia was prolonged, reaching a nadir during days 7-9 in the second week of illness before returning towards normal after five weeks, with the lowest mean CD4+ cell count of 317 cells x 10⁶/L at day 7, and CD8+ cell count of 239 cells × 10⁶/L at day 8. Patients with more severe clinical illness, or patients who died, had significantly more profound CD4+ and CD8+ lymphopenia. Discussion: Lymphopenia is a prominent part of SARS-CoV infection and lymphocyte counts may be useful in predicting the severity and clinical outcomes. Possible reasons for the SARS-associated lymphopenia may be direct infection of lymphocytes by SARS-CoV, lymphocyte sequestration in the lung or cytokine-mediated lymphocyte trafficking. There may also be immune-mediated lymphocyte destruction, bone marrow or thymus suppression, or apoptosis.

A01	`01`	`1`		`@0 1201-9712`
A03		`1`		`@0 Int. j. infect. dis.`
A05				`@2 9`
A06				`@2 6`
A08	`01`	`1`	`ENG`	`@1 Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets`
A11	`01`	`1`		`@1 ZHONGPING HE`
A11	`02`	`1`		`@1 CHUNHUI ZHAO`
A11	`03`	`1`		`@1 QINGMING DONG`
A11	`04`	`1`		`@1 HUI ZHUANG`
A11	`05`	`1`		`@1 SHUJING SONG`
A11	`06`	`1`		`@1 GUOAI PENG`
A11	`07`	`1`		`@1 DWYER (Dominic E.)`
A14	`01`			`@1 Capital University of Medical Sciences Affiliated Beijing YouAn Hospital @2 Beijing 100054 @3 CHN @Z 1 aut. @Z 2 aut.`
A14	`02`			`@1 Beijing Ditan Hospital @2 Beijing 100011 @3 CHN @Z 3 aut. @Z 5 aut. @Z 6 aut.`
A14	`03`			`@1 Department of Microbiology, Peking University Health Science Center @2 Beijing 100083 @3 CHN @Z 4 aut.`
A14	`04`			`@1 Center for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, Westmead Hospital @2 Westmead NSW 2145 @3 AUS @Z 7 aut.`
A20				`@1 323-330`
A21				`@1 2005`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 26659 @5 354000132518560040`
A44				`@0 0000 @1 © 2005 INIST-CNRS. All rights reserved.`
A45				`@0 24 ref.`
A47	`01`	`1`		`@0 05-0496221`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 International journal of infectious diseases`
A66	`01`			`@0 CAN`
C01	`01`		`ENG`	@0 Introduction: Severe acute respiratory syndrome (SARS) caused large outbreaks of atypical pneumonia in 2003, with the largest localized outbreak occurring in Beijing, China. Lymphopenia was prominent amongst the laboratory abnormalities reported in acute SARS. Methods: The effect of SARS on peripheral blood lymphocytes and their subsets was examined in 271 SARS coronavirus-infected individuals. Results: There was a significant decrease in the CD45+, CD3+, CD4+, CD8+, CD19+ and CD16+/56+ cell counts over the five weeks of the SARS illness although CD4+/CD8+ ratios did not change significantly. The lymphopenia was prolonged, reaching a nadir during days 7-9 in the second week of illness before returning towards normal after five weeks, with the lowest mean CD4+ cell count of 317 cells x 10⁶/L at day 7, and CD8+ cell count of 239 cells × 10⁶/L at day 8. Patients with more severe clinical illness, or patients who died, had significantly more profound CD4+ and CD8+ lymphopenia. Discussion: Lymphopenia is a prominent part of SARS-CoV infection and lymphocyte counts may be useful in predicting the severity and clinical outcomes. Possible reasons for the SARS-associated lymphopenia may be direct infection of lymphocytes by SARS-CoV, lymphocyte sequestration in the lung or cytokine-mediated lymphocyte trafficking. There may also be immune-mediated lymphocyte destruction, bone marrow or thymus suppression, or apoptosis.
C02	`01`	`X`		`@0 002B05C02C`
C02	`02`	`X`		`@0 002B05B02M`
C02	`03`	`X`		`@0 002B19D`
C03	`01`	`X`	`FRE`	`@0 Syndrome respiratoire aigu sévère @2 NM @5 01`
C03	`01`	`X`	`ENG`	`@0 Severe acute respiratory syndrome @2 NM @5 01`
C03	`01`	`X`	`SPA`	`@0 Síndrome respiratorio agudo severo @2 NM @5 01`
C03	`02`	`X`	`FRE`	`@0 Bactériémie @5 02`
C03	`02`	`X`	`ENG`	`@0 Bacteremia @5 02`
C03	`02`	`X`	`SPA`	`@0 Bacteriemia @5 02`
C03	`03`	`X`	`FRE`	`@0 Lymphopénie @5 03`
C03	`03`	`X`	`ENG`	`@0 Lymphocytopenia @5 03`
C03	`03`	`X`	`SPA`	`@0 Linfopenia @5 03`
C03	`04`	`X`	`FRE`	`@0 Sous population cellulaire @5 07`
C03	`04`	`X`	`ENG`	`@0 Cell subpopulation @5 07`
C03	`04`	`X`	`SPA`	`@0 Subpoblación celular @5 07`
C03	`05`	`X`	`FRE`	`@0 Lymphocyte @5 08`
C03	`05`	`X`	`ENG`	`@0 Lymphocyte @5 08`
C03	`05`	`X`	`SPA`	`@0 Linfocito @5 08`
C03	`06`	`X`	`FRE`	`@0 Coronavirus @2 NW @5 10`
C03	`06`	`X`	`ENG`	`@0 Coronavirus @2 NW @5 10`
C03	`06`	`X`	`SPA`	`@0 Coronavirus @2 NW @5 10`
C03	`07`	`X`	`FRE`	`@0 Antigène CD4 @4 INC @5 86`
C03	`08`	`X`	`FRE`	`@0 Antigène CD8 @4 INC @5 87`
C07	`01`	`X`	`FRE`	`@0 Virose`
C07	`01`	`X`	`ENG`	`@0 Viral disease`
C07	`01`	`X`	`SPA`	`@0 Virosis`
C07	`02`	`X`	`FRE`	`@0 Infection`
C07	`02`	`X`	`ENG`	`@0 Infection`
C07	`02`	`X`	`SPA`	`@0 Infección`
C07	`03`	`X`	`FRE`	`@0 Bactériose`
C07	`03`	`X`	`ENG`	`@0 Bacteriosis`
C07	`03`	`X`	`SPA`	`@0 Bacteriosis`
C07	`04`	`X`	`FRE`	`@0 Coronaviridae @2 NW`
C07	`04`	`X`	`ENG`	`@0 Coronaviridae @2 NW`
C07	`04`	`X`	`SPA`	`@0 Coronaviridae @2 NW`
C07	`05`	`X`	`FRE`	`@0 Nidovirales @2 NW`
C07	`05`	`X`	`ENG`	`@0 Nidovirales @2 NW`
C07	`05`	`X`	`SPA`	`@0 Nidovirales @2 NW`
C07	`06`	`X`	`FRE`	`@0 Virus @2 NW`
C07	`06`	`X`	`ENG`	`@0 Virus @2 NW`
C07	`06`	`X`	`SPA`	`@0 Virus @2 NW`
C07	`07`	`X`	`FRE`	`@0 Appareil respiratoire pathologie @5 38`
C07	`07`	`X`	`ENG`	`@0 Respiratory disease @5 38`
C07	`07`	`X`	`SPA`	`@0 Aparato respiratorio patología @5 38`
C07	`08`	`X`	`FRE`	`@0 Poumon pathologie @5 39`
C07	`08`	`X`	`ENG`	`@0 Lung disease @5 39`
C07	`08`	`X`	`SPA`	`@0 Pulmón patología @5 39`
C07	`09`	`X`	`FRE`	`@0 Hémopathie @5 40`
C07	`09`	`X`	`ENG`	`@0 Hemopathy @5 40`
C07	`09`	`X`	`SPA`	`@0 Hemopatía @5 40`
C07	`10`	`X`	`FRE`	`@0 Leucopénie @5 41`
C07	`10`	`X`	`ENG`	`@0 Leukopenia @5 41`
C07	`10`	`X`	`SPA`	`@0 Leucopenia @5 41`
N21				`@1 346`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000574

Links to Exploration step

Pascal:05-0496221

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets</title>
<author><name sortKey="Zhongping He" sort="Zhongping He" uniqKey="Zhongping He" last="Zhongping He">ZHONGPING HE</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Capital University of Medical Sciences Affiliated Beijing YouAn Hospital</s1>
<s2>Beijing 100054</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
</affiliation>
</author>
<author><name sortKey="Chunhui Zhao" sort="Chunhui Zhao" uniqKey="Chunhui Zhao" last="Chunhui Zhao">CHUNHUI ZHAO</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Capital University of Medical Sciences Affiliated Beijing YouAn Hospital</s1>
<s2>Beijing 100054</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
</affiliation>
</author>
<author><name sortKey="Qingming Dong" sort="Qingming Dong" uniqKey="Qingming Dong" last="Qingming Dong">QINGMING DONG</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Beijing Ditan Hospital</s1>
<s2>Beijing 100011</s2>
<s3>CHN</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
</affiliation>
</author>
<author><name sortKey="Hui Zhuang" sort="Hui Zhuang" uniqKey="Hui Zhuang" last="Hui Zhuang">HUI ZHUANG</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Microbiology, Peking University Health Science Center</s1>
<s2>Beijing 100083</s2>
<s3>CHN</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
</affiliation>
</author>
<author><name sortKey="Shujing Song" sort="Shujing Song" uniqKey="Shujing Song" last="Shujing Song">SHUJING SONG</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Beijing Ditan Hospital</s1>
<s2>Beijing 100011</s2>
<s3>CHN</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
</affiliation>
</author>
<author><name sortKey="Guoai Peng" sort="Guoai Peng" uniqKey="Guoai Peng" last="Guoai Peng">GUOAI PENG</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Beijing Ditan Hospital</s1>
<s2>Beijing 100011</s2>
<s3>CHN</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
</affiliation>
</author>
<author><name sortKey="Dwyer, Dominic E" sort="Dwyer, Dominic E" uniqKey="Dwyer D" first="Dominic E." last="Dwyer">Dominic E. Dwyer</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Center for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, Westmead Hospital</s1>
<s2>Westmead NSW 2145</s2>
<s3>AUS</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">05-0496221</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0496221 INIST</idno>
<idno type="RBID">Pascal:05-0496221</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000574</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000416</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets</title>
<author><name sortKey="Zhongping He" sort="Zhongping He" uniqKey="Zhongping He" last="Zhongping He">ZHONGPING HE</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Capital University of Medical Sciences Affiliated Beijing YouAn Hospital</s1>
<s2>Beijing 100054</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
</affiliation>
</author>
<author><name sortKey="Chunhui Zhao" sort="Chunhui Zhao" uniqKey="Chunhui Zhao" last="Chunhui Zhao">CHUNHUI ZHAO</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Capital University of Medical Sciences Affiliated Beijing YouAn Hospital</s1>
<s2>Beijing 100054</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
</affiliation>
</author>
<author><name sortKey="Qingming Dong" sort="Qingming Dong" uniqKey="Qingming Dong" last="Qingming Dong">QINGMING DONG</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Beijing Ditan Hospital</s1>
<s2>Beijing 100011</s2>
<s3>CHN</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
</affiliation>
</author>
<author><name sortKey="Hui Zhuang" sort="Hui Zhuang" uniqKey="Hui Zhuang" last="Hui Zhuang">HUI ZHUANG</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Microbiology, Peking University Health Science Center</s1>
<s2>Beijing 100083</s2>
<s3>CHN</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
</affiliation>
</author>
<author><name sortKey="Shujing Song" sort="Shujing Song" uniqKey="Shujing Song" last="Shujing Song">SHUJING SONG</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Beijing Ditan Hospital</s1>
<s2>Beijing 100011</s2>
<s3>CHN</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
</affiliation>
</author>
<author><name sortKey="Guoai Peng" sort="Guoai Peng" uniqKey="Guoai Peng" last="Guoai Peng">GUOAI PENG</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Beijing Ditan Hospital</s1>
<s2>Beijing 100011</s2>
<s3>CHN</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
</affiliation>
</author>
<author><name sortKey="Dwyer, Dominic E" sort="Dwyer, Dominic E" uniqKey="Dwyer D" first="Dominic E." last="Dwyer">Dominic E. Dwyer</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Center for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, Westmead Hospital</s1>
<s2>Westmead NSW 2145</s2>
<s3>AUS</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">International journal of infectious diseases</title>
<title level="j" type="abbreviated">Int. j. infect. dis.</title>
<idno type="ISSN">1201-9712</idno>
<imprint><date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">International journal of infectious diseases</title>
<title level="j" type="abbreviated">Int. j. infect. dis.</title>
<idno type="ISSN">1201-9712</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Bacteremia</term>
<term>Cell subpopulation</term>
<term>Coronavirus</term>
<term>Lymphocyte</term>
<term>Lymphocytopenia</term>
<term>Severe acute respiratory syndrome</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term>
<term>Bactériémie</term>
<term>Lymphopénie</term>
<term>Sous population cellulaire</term>
<term>Lymphocyte</term>
<term>Coronavirus</term>
<term>Antigène CD4</term>
<term>Antigène CD8</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Introduction: Severe acute respiratory syndrome (SARS) caused large outbreaks of atypical pneumonia in 2003, with the largest localized outbreak occurring in Beijing, China. Lymphopenia was prominent amongst the laboratory abnormalities reported in acute SARS. Methods: The effect of SARS on peripheral blood lymphocytes and their subsets was examined in 271 SARS coronavirus-infected individuals. Results: There was a significant decrease in the CD45+, CD3+, CD4+, CD8+, CD19+ and CD16+/56+ cell counts over the five weeks of the SARS illness although CD4+/CD8+ ratios did not change significantly. The lymphopenia was prolonged, reaching a nadir during days 7-9 in the second week of illness before returning towards normal after five weeks, with the lowest mean CD4+ cell count of 317 cells x 10<sup>6</sup>
/L at day 7, and CD8+ cell count of 239 cells × 10<sup>6</sup>
/L at day 8. Patients with more severe clinical illness, or patients who died, had significantly more profound CD4+ and CD8+ lymphopenia. Discussion: Lymphopenia is a prominent part of SARS-CoV infection and lymphocyte counts may be useful in predicting the severity and clinical outcomes. Possible reasons for the SARS-associated lymphopenia may be direct infection of lymphocytes by SARS-CoV, lymphocyte sequestration in the lung or cytokine-mediated lymphocyte trafficking. There may also be immune-mediated lymphocyte destruction, bone marrow or thymus suppression, or apoptosis.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>1201-9712</s0>
</fA01>
<fA03 i2="1"><s0>Int. j. infect. dis.</s0>
</fA03>
<fA05><s2>9</s2>
</fA05>
<fA06><s2>6</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>ZHONGPING HE</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>CHUNHUI ZHAO</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>QINGMING DONG</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>HUI ZHUANG</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>SHUJING SONG</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>GUOAI PENG</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>DWYER (Dominic E.)</s1>
</fA11>
<fA14 i1="01"><s1>Capital University of Medical Sciences Affiliated Beijing YouAn Hospital</s1>
<s2>Beijing 100054</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Beijing Ditan Hospital</s1>
<s2>Beijing 100011</s2>
<s3>CHN</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Microbiology, Peking University Health Science Center</s1>
<s2>Beijing 100083</s2>
<s3>CHN</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Center for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, Westmead Hospital</s1>
<s2>Westmead NSW 2145</s2>
<s3>AUS</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA20><s1>323-330</s1>
</fA20>
<fA21><s1>2005</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>26659</s2>
<s5>354000132518560040</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2005 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>24 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>05-0496221</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>International journal of infectious diseases</s0>
</fA64>
<fA66 i1="01"><s0>CAN</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Introduction: Severe acute respiratory syndrome (SARS) caused large outbreaks of atypical pneumonia in 2003, with the largest localized outbreak occurring in Beijing, China. Lymphopenia was prominent amongst the laboratory abnormalities reported in acute SARS. Methods: The effect of SARS on peripheral blood lymphocytes and their subsets was examined in 271 SARS coronavirus-infected individuals. Results: There was a significant decrease in the CD45+, CD3+, CD4+, CD8+, CD19+ and CD16+/56+ cell counts over the five weeks of the SARS illness although CD4+/CD8+ ratios did not change significantly. The lymphopenia was prolonged, reaching a nadir during days 7-9 in the second week of illness before returning towards normal after five weeks, with the lowest mean CD4+ cell count of 317 cells x 10<sup>6</sup>
/L at day 7, and CD8+ cell count of 239 cells × 10<sup>6</sup>
/L at day 8. Patients with more severe clinical illness, or patients who died, had significantly more profound CD4+ and CD8+ lymphopenia. Discussion: Lymphopenia is a prominent part of SARS-CoV infection and lymphocyte counts may be useful in predicting the severity and clinical outcomes. Possible reasons for the SARS-associated lymphopenia may be direct infection of lymphocytes by SARS-CoV, lymphocyte sequestration in the lung or cytokine-mediated lymphocyte trafficking. There may also be immune-mediated lymphocyte destruction, bone marrow or thymus suppression, or apoptosis.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B05C02C</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B05B02M</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B19D</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Syndrome respiratoire aigu sévère</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Severe acute respiratory syndrome</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Síndrome respiratorio agudo severo</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Bactériémie</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Bacteremia</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Bacteriemia</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Lymphopénie</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Lymphocytopenia</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Linfopenia</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Sous population cellulaire</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Cell subpopulation</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Subpoblación celular</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Lymphocyte</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Lymphocyte</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Linfocito</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Coronavirus</s0>
<s2>NW</s2>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Coronavirus</s0>
<s2>NW</s2>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Coronavirus</s0>
<s2>NW</s2>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Antigène CD4</s0>
<s4>INC</s4>
<s5>86</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Antigène CD8</s0>
<s4>INC</s4>
<s5>87</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Virose</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Viral disease</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Virosis</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Infección</s0>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Bactériose</s0>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Bacteriosis</s0>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Bacteriosis</s0>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Appareil respiratoire pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Respiratory disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Aparato respiratorio patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Poumon pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Lung disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Pulmón patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="09" i2="X" l="FRE"><s0>Hémopathie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG"><s0>Hemopathy</s0>
<s5>40</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA"><s0>Hemopatía</s0>
<s5>40</s5>
</fC07>
<fC07 i1="10" i2="X" l="FRE"><s0>Leucopénie</s0>
<s5>41</s5>
</fC07>
<fC07 i1="10" i2="X" l="ENG"><s0>Leukopenia</s0>
<s5>41</s5>
</fC07>
<fC07 i1="10" i2="X" l="SPA"><s0>Leucopenia</s0>
<s5>41</s5>
</fC07>
<fN21><s1>346</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000416 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000416 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:05-0496221
   |texte=   Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets

Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri